Tengjun Biotechnology Corp
Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, packaging, distributing, and marketing featured dandelion teas and water purifiers in the People's Republic of China. It offers black and green dandelion teas; and household water purifiers. The company was founded in 2010 and is headquartered in Jining, China.
Tengjun Biotechnology Corp (TJBH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 1.344x
Based on the latest financial reports, Tengjun Biotechnology Corp (TJBH) has a cash flow conversion efficiency ratio of 1.344x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($20.52 Million) by net assets ($15.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tengjun Biotechnology Corp - Cash Flow Conversion Efficiency Trend (2015–2022)
This chart illustrates how Tengjun Biotechnology Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tengjun Biotechnology Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tengjun Biotechnology Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jaeyoung Solutec Co. Ltd
KQ:049630
|
-0.040x |
|
Shanghai Smart Control Co. Ltd.
SHE:001266
|
0.082x |
|
Finwise Bancorp
NASDAQ:FINW
|
0.018x |
|
Heritage Foods Limited
NSE:HERITGFOOD
|
0.236x |
|
EXPLOS. PROD. CHIM.EO 31
F:9Z50
|
N/A |
|
OP Bancorp
NASDAQ:OPBK
|
0.105x |
|
Awfis Space Solutions Ltd
NSE:AWFIS
|
0.565x |
|
Commerce.com, Inc.
NASDAQ:CMRC
|
0.246x |
Annual Cash Flow Conversion Efficiency for Tengjun Biotechnology Corp (2015–2022)
The table below shows the annual cash flow conversion efficiency of Tengjun Biotechnology Corp from 2015 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $14.97 Million | $1.35 Million | 0.090x | -63.35% |
| 2021-12-31 | $-2.29 Million | $-561.30K | 0.246x | +118.42% |
| 2020-12-31 | $-282.50K | $-31.76K | 0.112x | -20.99% |
| 2019-12-31 | $-279.64K | $-39.79K | 0.142x | +14.60% |
| 2018-12-31 | $-245.15K | $-30.44K | 0.124x | -15.99% |
| 2017-12-31 | $-215.25K | $-31.81K | 0.148x | -32.39% |
| 2016-12-31 | $-202.07K | $-44.17K | 0.219x | -46.87% |
| 2015-12-31 | $-156.29K | $-64.30K | 0.411x | -- |